Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABCF2-H2BK1 readthrough is a gene locus resulting from readthrough transcription between the ABCF2 gene (encoding a member of the ATP-binding cassette (ABC) transporter family) and a downstream histone H2B-like gene (H2BK1)[2][3][5]. This entity encodes a chimeric transcript, but has not been widely characterized as an independent protein with established function, targetability, or clinical significance. It is catalogued as a protein-coding locus, but both function and biological importance remain unclear; its existence primarily reflects an annotation artifact due to readthrough events between neighboring genes[2][3][5]. Key points supporting this annotation: - The genomic entry corresponds to a readthrough transcript, not a unique, well-characterized protein or classical drug target[2][3]. - There is no functional or mechanistic data supporting its role as a receptor, enzyme, transporter, or established molecular target for drug discovery[2][3][5][6]. - No known interacting drugs, disease roles, biomarkers, or mechanism-of-action data are associated with the locus in literature or protein databases as of this update[2][3][5][6][7]. Reason for is_incorrect: true - This "target" reflects a readthrough artifact and does not represent an established, actionable therapeutic or molecular target as defined in pharmacology, translational medicine, or molecular biology[2][3][5]. No validated function can be assigned, and its alternative names also refer to the same locus. In molecular target databases, such entries are generally not used for therapeutic targeting. Summary: ABCF2-H2BK1 readthrough is a genomic artifact resulting from readthrough transcription between ABCF2 and H2BK1, with no recognized functional significance or therapeutic targeting potential[2][3][5].
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ABCF2-H2BK1 readthrough (ABCF2-H2BK1).